BTN2A1 and Alzheimer disease: On the contrary, we found that BTN2A1 was associated with decreased risk of AD, anxiety, and SCZ, which is consistent with a report that BTN2A1 is involved in the immunomodulation of the activity of γδ T-cells and has significant anti-neuroinflammatory and neuroprotective effects51.